Mariano Valdes

Showing 1-4 of 4 articles

Coronary interventions

A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)

Garcia-Touchard A, Goicolea J, Sabaté M, Alfonso F, Ruiz-Salmeron R, Bethencourt A, Gonzalo N, Miranda F, García del Blanco B, Jimenez Mazuecos J, Melgares R, Martinez-Romero P, Hernandez-Garcia J, Lezaun R, Bullones J, Fernandez-Portales J, Rumoroso J-R, Ortas R, Valdes M, Trillo R, Brugaletta S, Otzuki S, Hernández Pérez FJ, Alonso-Pulpón L

January 20, 2017 | 10.4244/EIJ-D-16-00128

Coronary interventions

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

Fajadet J, Neumann F, Hildick-Smith D, Petronio A, Zaman A, Spence M, Wöhrle J, Elhadad S, Roberts D, Hovasse T, Valdes M, Silber S

January 20, 2017 | 10.4244/EIJV12I13A262

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial

Vlachojannis G, Smits P, Hofma S, Togni M, Vázquez N, Valdes M, Voudris V, Puricel S, Slagboom T, Goy J-J, den Heijer P, van der Ent M

July 20, 2015 | 10.4244/EIJV11I3A53

A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated By EveroLimus-Eluting Stent) trial

Moreno R, Garcia E, Teles R, Almeida M, Carvalho H, Sabaté M, Martin-Reyes R, Rumoroso J-R, Galeote G, Goicolea F, Moreu J, Mainar V, Mauri J, Ferreira R, Valdes M, Pérez de Prado A, Martin-Yuste V, Jiménez-Valero S, Sanchez Recalde A, Calvo L, de Sa E, Macaya C, López-Sendón J-L

May 25, 2010

1

Latest news

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

October 19, 2021

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

October 15, 2021

My Stroke Story

October 20, 2021

Transcatheter Paravalvular Leak Closure: Catch Me If You Can

Thomas Pilgrim et al.

October 20, 2021

STATE OF THE ART

Glucose-Lowering Therapy in Patients undergoing Percutaneous Coronary Intervention

Isabelle Johansson et al.

October 1, 2021

Valvular disease